Sort
23,748 grants matching “melanoma”
The role of regulation and subcellular localization of GTP biosynthesis in melanoma invasion and metastasis
$499,833Mikhail Nikiforov · Duke University · R01 · FY2025 · CA
Exploring the Function of MHC-II/Lag3 Axis in Brain Metastasis to Develop Novel Therapeutic Strategies
$499,828Dihua Yu · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Epigenetic and microenvironmental regulation of dormant disseminated cancer
$499,826Julio A Aguirre-Ghiso · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA
Structural and functional characterization of T and NK cell receptors
$499,751Peter D. Sun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
CELL SURFACE STRUCTURE AND TRANSFORMATIONS
$499,675Massachusetts Institute Of Technology · R01 · FY2004 · CA
An integrated polymeric carrier for subunit cancer vaccines
$499,661Suzie H Pun · University Of Washington · R01 · FY2024 · CA
Brain tumors with regulatory T-cells treated with EGFRvIII-specific T-cells
$499,514John H Sampson · Duke University · R01 · FY2016 · CA
Community Outreach and Engagement
$499,268Carmen E Guerra · University Of Pennsylvania · P30 · FY2025 · CA
Immune profiling of multi-parameter flow cytometry using computational statistics
$499,203Cliburn C Chan · Duke University · RC1 · FY2009 · AI
Role of AMPK in melanoma brain metastasis
$499,166Bin Zheng · Massachusetts General Hospital · R01 · FY2023 · CA
Efficacy of Web-based Training in Skin Cancer Triage
$499,035Rhode Island Hospital · R01 · FY2004 · CA
Intratumoral Cytokine Immunotherapy Studies in Companion Canine Cancer Models
$498,957Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2023 · CA
Project 3 Immunotherapeutic Targeting of SLC45A2 for Treatment of Uveal Melanoma
$498,957Cassian Yee · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
Melanoma RAS/BRAF Mutation--Heterogeneity-Risk-Prognosis
$498,851Nancy E Thomas · Univ Of North Carolina Chapel Hill · R01 · FY2007 · CA
Melanoma RAS/BRAF Mutation: Heterogeneity-Risk-Prognosis
$498,844Nancy E Thomas · Univ Of North Carolina Chapel Hill · R01 · FY2009 · CA
Data Analysis Unit
$498,776Gad A Getz · Dana-Farber Cancer Inst · U2C · FY2021 · CA
Epigenetic mechanisms of transcriptional activation of a novel oncogenic ALK variant in cancer
$498,691Ping Chi · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Epigenetic mechanisms of transcriptional activation of a novel oncogenic ALK variant in cancer
$498,691Ping Chi · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Fecal Microbiota Transplant and PD-1 blockade in Melanoma
$498,492Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
Imaging Nonlinear Absorption of Biomarkers for Improved Detection of Melanoma
$498,459Warren S Warren · Duke University · RC1 · FY2010 · CA
Defining and targeting epigenetic plasticity-driven drug resistance and immune escape in melanoma
$498,307Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
The Role of T Cell Avidity in Determining Tumor Immunity and Autoimmunity
$498,243Arthur Hurwitz · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Understanding intrinsic resistance to direct KRAS inhibition in colorectal cancers
$498,202John D Gordan · University Of California, San Francisco · R37 · FY2024 · CA
Suppression of Melanoma Initiation and Progression by NM23-H1
$498,135David M Kaetzel · University Of Maryland Baltimore · R01 · FY2012 · CA
Detection of Prostate Cancer Genomic Signatures in Blood
$498,123Amin I Kassis · Harvard Medical School · RC1 · FY2010 · CA